Mangalam Organics Reports Q2 FY27 Results and Appoints Additional Independent Director
Mangalam Organics Ltd · Change in Management · 14 Nov 2026, 10:45 pm
Mangalam Organics Reports Q2 FY27 Results and Appoints Additional Independent Director Mangalam Organics reported consolidated revenue from operations of ₹28,146.12 lakh for Q2 ended 30th Sep'26, up 78.0% YoY from ₹15,810.13 lakh and 57.2% QoQ. Consolidated profit before tax rose 19.7% YoY to ₹499.99 lakh compared to ₹417.79 lakh in Q2 ended 30th Sep'25, with EPS at ₹3.74. Standalone revenue stood at ₹23,569.83 lakh. Additionally, the Board appointed Mr. Vaibhav Gandhi as an Additional Independent Director for a five-year term effective 14th Nov'26, subject to postal ballot shareholder approval.
Original exchange filing (PDF)
More announcements from Mangalam Organics Ltd
- Investor Presentation - September, 2026 · 17 Nov 2026
- The Board at its meeting held today has considered and approved the Standalone and Consolidated Unaudited Financial Statements along with the Limited Review report given by the statutory .... · 14 Nov 2026
- Mangalam Organics Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- The Board at its meeting held today, considered the following Matters: 1. Unaudited Standalone and Consolidated Financial Statements for the Second Quarter and Half Year ended September .... · 14 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters · 14 Nov 2026
- MANGALAM ORGANICS LIMITED has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2026 . · 14 Nov 2026
- Mangalam Organics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2026 ,inter alia, to consider and approve Unaudited Standalone and .... · 14 Nov 2026
- Appointment of the Statutory Auditor approved by the Shareholders at the 44th Annual General Meeting of the Company for the first consecutive term of Five Years · 26 Sept 2026
